Trial Profile
A Phase II, Open-Label, Multi-Center, Prospective, Randomized Study of LCP-Tacro Tablets vs. Azathioprine, in Combination With Corticosteroids, for the Treatment of Autoimmune Hepatitis
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary) ; Azathioprine; Prednisone
- Indications Autoimmune hepatitis
- Focus Therapeutic Use
- Sponsors Veloxis Pharmaceuticals
- 10 Jan 2020 Status changed from completed to discontinued.
- 11 Dec 2014 New trial record